| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Revenue | $10.3B | $9.4B | $9.5B | $10.1B | $9.4B | $2.3B | $2.6B |
| Cost of Revenue | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — |
| SG&A Expense | $1.3B | $1.2B | $1.3B | $1.3B | $1.2B | $1.1B | $1.3B |
| Operating Income | $0.5B | $0.3B | $0.2B | $0.5B | $0.5B | $-0.1B | $0.2B |
| Net Income | $0.1B | $0.1B | $-0.0B | $0.2B | $0.3B | $-0.0B | $0.0B |
| EPS (Basic) | $0.38 | $0.57 | $-0.16 | $0.87 | $1.12 | $-0.12 | $0.01 |
| EPS (Diluted) | $0.38 | $0.56 | $-0.16 | $0.86 | $1.10 | $-0.12 | $0.01 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $7.7B | $7.5B | $7.8B | $7.9B | $7.9B | $7.3B | $7.2B |
| Current Assets | $2.8B | $2.7B | $2.8B | $2.8B | $2.8B | $2.9B | $2.9B |
| Cash & Equivalents | $0.8B | $0.8B | $0.8B | $0.6B | $0.8B | $1.1B | $0.8B |
| Total Liabilities | $5.7B | $5.8B | $6.1B | $6.3B | $6.4B | $6.2B | $5.9B |
| Current Liabilities | $2.6B | $2.3B | $2.4B | $2.4B | $2.4B | $2.1B | $2.3B |
| Stockholders' Equity | $2.0B | $1.8B | $1.7B | $1.7B | $1.4B | $1.1B | $1.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.2B | $0.2B | $0.0B | $0.5B | $-0.0B | $0.3B |
| Investing Cash Flow | $-0.0B | $0.1B | $0.0B | $-0.1B | $-0.7B | $-0.3B | $-0.3B |
| Capital Expenditures | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B |
| Financing Cash Flow | $-0.4B | $-0.3B | $-0.1B | $-0.1B | $-0.1B | $0.6B | $-0.1B |